» Articles » PMID: 35425823

Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients

Abstract

Background: An increasing proportion of patients with acute myocardial infarction (AMI) are presenting without standard modifiable risk factors (SMuRFs) of hypertension, hypercholesterolemia, diabetes, and smoking, but with an unexpectedly increased mortality. This study examined the SMuRF-less patients presenting with AMI in a multiethnic Asian population.

Methods: We recruited patients presenting with AMI from 2011 to 2021 and compared the prevalence, clinical characteristics, and outcomes of SMuRF-less and SMuRF patients. Multivariable analysis was used to compare the outcomes of 30-day cardiovascular mortality, all-cause mortality, readmission, cardiogenic shock, stroke, and heart failure. Kaplan-Meier curves were constructed for 30-day cardiovascular mortality, with stratification by ethnicity, gender and AMI type, and 10-year all-cause mortality.

Results: Standard modifiable risk factor-less patients, who made up 8.6% of 8,680 patients, were significantly younger with fewer comorbidities that include stroke and chronic kidney disease, but higher rates of ventricular arrhythmias and inotropic or invasive ventilation requirement. Multivariable analysis showed higher rates of cardiovascular mortality (HR 1.48, 95% CI: 1.09-1.86, = 0.048), cardiogenic shock (RR: 1.31, 95% CI: 1.09-1.52, = 0.015), and stroke (RR: 2.51, 95% CI: 1.67-3.34, = 0.030) among SMuRF-less patients. A 30-day cardiovascular mortality was raised in the SMuRF-less group, with similar trends in men, patients with ST-segment elevation myocardial infarction (STEMI), and the three Asian ethnicities. All-cause mortality remains increased in the SMuRF-less group for up to 5 years.

Conclusion: There is a significant proportion of patients with AMI without standard risk factors in Asia, who have worse short-term mortality. This calls for greater focus on the management of this unexpectedly high-risk subgroup of patients.

Citing Articles

Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.

Hammoudeh A, Aldalalah M, Smadi E, Alrishoud D, Alomari A, Alkhawaldeh M Vasc Health Risk Manag. 2025; 21:39-50.

PMID: 39931041 PMC: 11807772. DOI: 10.2147/VHRM.S499355.


A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction.

Kong G, Koh J, Chia J, Neo B, Chen Y, Cao G Cardiovasc Diabetol. 2025; 24(1):59.

PMID: 39920748 PMC: 11806904. DOI: 10.1186/s12933-024-02552-0.


Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.

Anand V, Koh J, Teo T, Chin Y, Mahesh R, Chan M Clin Res Cardiol. 2024; .

PMID: 39531081 DOI: 10.1007/s00392-024-02563-7.


Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors.

Zhang X, Du Y, Zhang T, Zhao Z, Guo Q, Ma X Cardiovasc Diabetol. 2024; 23(1):270.

PMID: 39044255 PMC: 11267681. DOI: 10.1186/s12933-024-02345-5.


Prevalence, predictors, and in-hospital outcomes of ST-elevation myocardial infarction among young adults without traditional cardiovascular risk factors in the United States.

Shamaki G, Safiriyu I, Antia A, Abd El-Radi W, Tinago C, Ilonze O Am Heart J Plus. 2024; 43:100408.

PMID: 38882592 PMC: 11177073. DOI: 10.1016/j.ahjo.2024.100408.


References
1.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

2.
Piironen M, Ukkola O, Huikuri H, Havulinna A, Koukkunen H, Mustonen J . Trends in long-term prognosis after acute coronary syndrome. Eur J Prev Cardiol. 2016; 24(3):274-280. DOI: 10.1177/2047487316679522. View

3.
Wong C, Loh S, Loh K, Ong P, Foo D, Ho H . Acute myocardial infarction: Clinical features and outcomes in young adults in Singapore. World J Cardiol. 2012; 4(6):206-10. PMC: 3386311. DOI: 10.4330/wjc.v4.i6.206. View

4.
Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T . Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008; 117(12):1610-9. DOI: 10.1161/CIRCULATIONAHA.107.188629. View

5.
Manuel D, Lim J, Tanuseputro P, Anderson G, Alter D, Laupacis A . Revisiting Rose: strategies for reducing coronary heart disease. BMJ. 2006; 332(7542):659-62. PMC: 1403258. DOI: 10.1136/bmj.332.7542.659. View